Congress of European Crohn's and Colitis Organisation

Healio brings you the highlights from the Congress of European Crohn's and Colitis Organisation. Refer back to this page often for the latest news from ECCO, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News

HIV drug candidate shows promise in ulcerative colitis

March 18, 2019
Data from a proof of concept study presented at the Congress of the European Crohn’s and Colitis Organisation indicated that ABX464, a novel…
Meeting News

Intensive treatment within the first year prevents early Crohn’s progression

March 14, 2019
Patients with early Crohn’s disease who can achieve endoscopic or deep remission after one year of treatment are less likely to experience…
Meeting News

GEMINI: Entyvio safe long-term for Crohn’s, ulcerative colitis

March 13, 2019
Final results from the GEMINI trial revealed that Entyvio had a suitable safety profile for long-term treatment of inflammatory bowel disease…
Meeting News

Mirikizumab displays long-term efficacy for ulcerative colitis maintenance

March 13, 2019
Targeting the interlieukin-23 pathway with mirikizumab, a p19-directed IL-23 antibody, may be an effective option for maintenance therapy in…
Meeting News

Entyvio superior to Humira in moderate, severe ulcerative colitis

March 13, 2019
Entyvio conferred superior clinical remission and mucosal healing compared with Humira among patients with moderately to severely active ulcerative…
Meeting News

Optimization helps patients with Crohn’s recapture Stelara response

March 12, 2019
Patients with Crohn’s disease who either lost or had inadequate response to therapy with Stelara were able to recapture that response by having…
Meeting News

Data support controlled-release cyclosporine to treat ulcerative colitis

March 12, 2019
Data presented at the Congress of the European Crohn’s and Colitis Organisation support further development of ST-0529 — a low-dose…
Meeting NewsVideo

VIDEO: Novel patient-reported QOL tool may improve clinical trial outcomes in IBD

March 12, 2019
In this exclusive video from the Congress of the European Crohn’s and Colitis Organisation, Peter D.R. Higgins, MD, PhD, director of the IBD…

Upadacitinib effective in ulcerative colitis induction

March 11, 2019
Patients treated with upadacitinib for ulcerative colitis experienced better endoscopic and histologic outcomes as well as better mucosal healing…

Etrasimod induces endoscopic, histologic improvement in ulcerative colitis

March 11, 2019
Etrasimod — an oral, selective sphingosine-1-phosphate receptor modulator — was effective in inducing endoscopic and histologic…